Joanna Horobin
CIK 1560959 · Chief Medical Officer · last filed 2025-08-21
Joanna Horobin is a Chief Medical Officer who has filed 32 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing shows the insider sold $135.8K of LQDA on Aug 21, 2025. Across all open-market trades the lifetime net is −$408.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.41M
5
32
-$408.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 33,755 | $71.23 | $2.40M | -$135.8K | 7 | 2025-08-21 |
| KYMR | Director | 0 | $86.20 | $0 | -$280.4K | 5 | 2024-06-07 |
| Vyant Bio, Inc. (VYNT) Delisted | Director | 23,123 | $0.19 | $4.5K | $0 | 7 | 2023-01-19 |
| Aceragen, Inc. (IDRA) Delisted | Chief Medical Officer | 20,144 | $7.22 | $145.5K | $1.0K | 7 | 2019-07-11 |
| VSTM | Chief Medical Officer | 750 | $4.10 | $3.1K | $6.5K | 4 | 2015-01-12 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-21 | LQDA | Sell (S) | −5,000 | -$135.8K | EDGAR |
| 2025-06-20 | LQDA | Grant (A) | +18,396 | $0 | EDGAR |
| 2024-06-24 | LQDA | Grant (A) | +20,359 | $0 | EDGAR |
| 2024-06-07 | KYMR | Mixed | — | -$262.7K | EDGAR |
| 2023-06-21 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | KYMR | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | Vyant Bio, Inc. (VYNT) Delisted | Grant (A) | +7,526 | $0 | EDGAR |
| 2022-10-19 | Vyant Bio, Inc. (VYNT) Delisted | Grant (A) | +14,285 | $0 | EDGAR |
| 2022-07-29 | Vyant Bio, Inc. (VYNT) Delisted | Grant (A) | +8,092 | $0 | EDGAR |
| 2022-06-22 | LQDA | Grant (A) | — | $0 | EDGAR |